We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Advanced Oncotherapy plc (AVO) Ord 25p

Sell:1.93p Buy:1.93p 0 Change: No change
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Bid situation
Sell:1.93p
Buy:1.93p
Change: No change
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Bid situation
Sell:1.93p
Buy:1.93p
Change: No change
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Bid situation
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Advanced Oncotherapy Plc is a United Kingdom-based specialist developer and provider of a proton therapy system, the LIGHT system. The Company’s team, ADAM, based in Geneva, is focused on the development of a proprietary proton accelerator called, Linac Image Guided Hadron Technology (LIGHT). LIGHT's compact configuration delivers proton beams in a way that facilitates greater precision and electronic control. The linear design of LIGHT allows for active longitudinal modulation along the proton beam axis and the variation of the proton beam by electronic means during cancer treatment. The modular feature of LIGHT offers hospitals and treatment centers the flexibility to customize cancer treatment plans based on a range of energies. Its subsidiaries include ADAM S.A., Advanced Oncotherapy Americas Inc, Advanced Oncotherapy B.V., Advanced Oncotherapy Resources Ltd, APTS Harley Street Ltd, Advanced Oncotherapy (China) Ltd, Advanced Oncotherapy Proton Therapy Services Ltd and other.

Contact details

Address:
Third Fl, 4 Tenterden Street
LONDON
W1S 1TE
United Kingdom
Telephone:
+44 (020) 36178728
Website:
https://www.avoplc.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

EPIC:
AVO
ISIN:
GB00BD6SX109
Market cap:
£10.44 million
Shares in issue:
542.57 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Michael Sinclair
    Executive Chairman of the Board
  • Nicolas Serandour
    Chief Executive Officer, Executive Director
  • Ed Lee
    Chief Operating Officer, President, Europe
  • Berengere Pons-Chabord
    Senior Vice President - Corporate Finance
  • Louise Harley-Smeur
    Senior Vice President - Intellectual Property
  • Graham Pughe
    Senior Vice President - Accounting
  • Wim Hulsbergen
    Vice President - IT Services
  • Steve Myers
    Executive Director, Executive Chairman of ADAM
  • Bridget Biggar
    Human Resources Director
  • Michel Baelen
    Director - Regulatory Affairs

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.